Pancreatic Neuroendocrine Tumour (pancreatic + neuroendocrine_tumour)

Distribution by Scientific Domains


Selected Abstracts


Re: Pancreatic Neuroendocrine tumour (PNET) occurring with Guillian-Barré syndrome (ANZ J. Surg.

ANZ JOURNAL OF SURGERY, Issue 7-8 2010
2010; 80: 297)
No abstract is available for this article. [source]


Pancreatic neuroendocrine tumour occurring with Guillian-Barré syndrome

ANZ JOURNAL OF SURGERY, Issue 4 2010
MBChB, Tzu-Chien Yu BHB
No abstract is available for this article. [source]


Cytomorphological and imunohistochemical evaluation of a cystic pancreatic neuroendocrine tumour

CYTOPATHOLOGY, Issue 6 2007
B. Shah
No abstract is available for this article. [source]


Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma

INTERNAL MEDICINE JOURNAL, Issue 6 2007
M. L. Healy
Abstract Insulinomas are the most common hormone-producing pancreatic neuroendocrine tumours (NETs), and patients usually present with symptoms secondary to hypoglycaemia. Octreotide has been widely used in the symptomatic treatment of patients with pancreatic NETs, including insulinomas. We describe a case of a patient with a metastatic NET, subsequently identified as a malignant insulinoma, who developed severe hypoglycaemia after treatment with long-acting octreotide. [source]